Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.61 |
| ▸ | POLA1 | P09884 | 1/20 | 0.61 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | DGKA | P23743 | 1/20 | 0.52 |
| ▸ | CES2 | O00748 | 3/20 | 0.50 |
| ▸ | CES1 | P23141 | 3/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.49 |
| ▸ | CA7 | P43166 | 1/20 | 0.49 |
| ▸ | CA9 | Q16790 | 1/20 | 0.49 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.48 |
| ▸ | PPARG | P37231 | 6/20 | 0.48 |
| ▸ | PPARD | Q03181 | 6/20 | 0.48 |
| ▸ | PPARA | Q07869 | 6/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.48 |
| ▸ | TSHR | P16473 | 4/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3187580 | 1.00 | POLB (0.61) | POLBPOLA1HAO1KMT2AMAPT | |
| SCHEMBL1123527 | 1.00 | POLB (0.61) | POLBPOLA1HAO1KMT2AMAPT | |
| SCHEMBL6138719 | 1.00 | POLB (0.61) | POLBPOLA1HAO1KMT2AMAPT | |
| SCHEMBL6138711 | 1.00 | POLB (0.61) | POLBPOLA1HAO1KMT2AMAPT | |
| SCHEMBL18840606 | 1.00 | POLB (0.61) | POLBPOLA1HAO1KMT2AMAPT | |
| SCHEMBL6059806 | 1.00 | POLB (0.61) | POLBPOLA1HAO1KMT2AMAPT | |
| SCHEMBL1123664 | 1.00 | POLB (0.61) | POLBPOLA1HAO1KMT2AMAPT | |
| SCHEMBL6138959 | 1.00 | POLB (0.61) | POLBPOLA1HAO1KMT2AMAPT | |
| SCHEMBL3450636 | 1.00 | POLB (0.61) | POLBPOLA1HAO1KMT2AMAPT | |
| SCHEMBL6138940 | 1.00 | POLB (0.61) | POLBPOLA1HAO1KMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 158 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113203822-B | Application of compound, matrix effect compensator and analysis method of aroma components in plant extract | 中国烟草总公司郑州烟草研究院 | 2024-05-31 | — | — | CN | claimed |
| CN-116064442-A | Carbonyl reductase and application thereof in catalytic synthesis of (R) -beta-hydroxytetradecanoate methyl ester | 国蔷生物科技(南京)有限公司 | 2023-05-05 | — | — | CN | claimed |
| CN-109097344-B | Marine sphingolipid bacteria short-chain alcohol dehydrogenase mutant and application thereof | 浙江海洋大学 | 2021-10-22 | — | — | CN | claimed |
| CN-109022473-B | Method for preparing orlistat intermediate by enzyme method | 浙江海洋大学 | 2021-09-17 | — | — | CN | claimed |
| CN-109022473-A | A kind of method that enzyme process prepares orlistat intermediate | 浙江海洋大学 | 2018-12-18 | — | — | CN | claimed |
| CN-105828801-A | Composition comprising cyclodextrin and its derivative, anionic surfactant and polyalkylene glycol ether of alcohol, and use thereof | 莱雅公司 | 2016-08-03 | — | — | CN | claimed |
| CN-101538285-A | Ruthenium-chiral diphosphine ligand complex, preparation method of same, and use of same in catalytic hydrogenation of beta-carbonyl methyl myristate | CHONGQING ZEN PHARMACEUTICAL C | 2009-09-23 | — | — | CN | claimed |
| JP-6253889-A | — | — | None | — | — | JP | disclosed |
| EP-4692244-A1 | SILANE CROSSLINKABLE RESIN COMPOSITION, SILANE CROSSLINKED RESIN MOLDED PRODUCT, AND ELECTRICAL WIRE | FURUKAWA ELECTRIC CO., LTD. (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-20260022237-A1 | SILANE CROSSLINKABLE RESIN COMPOSITION, SILANE CROSSLINKED RESIN FORMED BODY, AND ELECTRIC WIRE | FURUKAWA ELECTRIC CO., LTD. (JP) | 2026-01-22 | — | — | US | disclosed |
| US-20240228451-A1 | METHODS OF SYNTHESIZING LIPSTATIN DERIVATIVES | PANAFINA, INC. | 2024-07-11 | — | — | US | disclosed |
| US-20240217993-A1 | METAL-CONTAINING SILYLOXY COMPOUND, METAL-CONTAINING SILYLOXY GROUP-COATED PARTICLES, METHOD FOR PRODUCING SAME, AND DISPERSION COMPOSITION | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-07-04 | — | — | US | disclosed |
| CN-113203822-B | Application of compound, matrix effect compensator and analysis method of aroma components in plant extract | 中国烟草总公司郑州烟草研究院 | 2024-05-31 | — | — | CN | disclosed |
| WO-1998050399-A1 | AMINOALKYL GLUCOSAMINE PHOSPHATE COMPOUNDS AND THEIR USE AS ADJUVANTS AND IMMUNOEFFECTORS | CORIXA CORPORATION (US) | 1998-11-12 | — | — | WO | disclosed |
| US-5516944-A | ENANTIOMORPHS WITH PHOSPHINE GROUPS FOR FORMING METAL COMPLEXES | HOFFMANN-LA ROCHE INC. (US) | 1996-05-14 | — | — | US | disclosed |
| US-5488172-A | Chiral phosphorus compounds | HOFFMANN-LA ROCHE INC. (US) | 1996-01-30 | — | — | US | disclosed |
| WO-1995028929-A1 | AMINOLINE-N-OXIDE ANTIMICROBIALS FOR USE AGAINST H. PYLORI INFECTIONS | RPMS TECHNOLOGY LIMITED (GB) | 1995-11-02 | — | — | WO | disclosed |
| EP-0398132-B1 | Phosphorous compounds | HOFFMANN LA ROCHE (CH) | 1995-09-20 | — | — | EP | disclosed |
| EP-0647648-A1 | Optically active phosphorus compounds | F. HOFFMANN-LA ROCHE AG (CH) | 1995-04-12 | — | — | EP | disclosed |
| JP-H06253889-A | PRODUCTION OF OPTICALLY ACTIVE 3-HYDROXYTETRADECANOIC ACID ESTER | ASAHI BREWERIES LTD | 1994-09-13 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240228451-A1 | METHODS OF SYNTHESIZING LIPSTATIN DERIVATIVES | PNLIP, LIPC, LIPE | POLB 943/4885POLA1 2107/4885HAO1 1962/4885 |
| US-20260022237-A1 | SILANE CROSSLINKABLE RESIN COMPOSITION, SILANE CROSSLINKED RESIN FORMED BODY, AND ELECTRIC WIRE | ITGA1, ITGB1, GJA1 | POLB 2142/4885POLA1 874/4885HAO1 799/4885 |
| US-20240217993-A1 | METAL-CONTAINING SILYLOXY COMPOUND, METAL-CONTAINING SILYLOXY GROUP-COATED PARTICLES, METHOD FOR PRODUCING SAME, AND DISPERSION COMPOSITION | ITGA5, TLN1, ITGAL | POLB 3692/4885POLA1 1859/4885HAO1 186/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.